stella
beta
Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura — Stella
Recruiting
Back to Thrombotic Microangiopathies trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(30 sites)
France
Chu Amiens, Amiens
Chu Angers, Angers
Chru Besanon, Besançon
Chu Bobigny, Bobigny
Hopital Jean Verdie, Bondy
Show all 30 locations
View full record on ClinicalTrials.gov